Health Inequality Rises in UK and Beyond as Wealth Dictates Lifespan

Inequality is taking a severe toll on public health, according to new figures from the UK. The number of years people can expect to live in good health has declined across the country, with the sharpest drops occurring in the most deprived areas.

While the lingering effects of the COVID-19 pandemic play a role, experts attribute the majority of the decline to cuts in health services imposed by the previous government. The data underscores stark disparities: residents in wealthy areas can expect nearly 20 more years of good health than those in deprived regions.

This pattern is not unique to the UK. Similar declines in health have been observed in the United States, Germany, Canada, and the Netherlands, highlighting a global trend.

The Health Foundation, a UK healthcare think tank, emphasizes actionable solutions: “Reducing smoking and improving diet and physical activity can delay the onset of illness and improve day-to-day wellbeing. Secure work, good-quality housing, and supportive local environments all influence physical and mental health.”

Billionaire-Backed Anti-Aging Ventures: A Solution or a Symptom?

As public health deteriorates, one might expect innovative solutions to emerge from the private sector. At first glance, initiatives like Retro Biosciences—backed by Sam Altman and focused on targeting “aging mechanisms to increase healthy lifespan”—and Altos Labs, which aims to reverse “disease, injury, and disabilities,” appear promising.

Other players include Hevolution, a Saudi initiative promoting the shift from lifespan to healthspan, and Prospera, a “free city” off the coast of Honduras where medical research is unrestricted. “Prospera is a unique place where we can do such things,” noted one businessman involved in the project.

Yet these ventures share a critical flaw: they prioritize gene therapy, stem cells, and other prohibitively expensive treatments that only benefit the wealthy—those already more likely to enjoy better health. Meanwhile, in the UK, Genflow is developing treatments to slow aging in dogs, ensuring the super-rich retain their pets in an artificially prolonged future.

A Global Pattern: Wealth Dictates Health Outcomes

This trend is not confined to Western economies. In Russia, for example, Moscovites live longer than residents in rural provinces, though regional variations—such as the relatively good health of non-drinkers in Muslim regions—complicate the picture. One might expect Russian President Vladimir Putin to address these disparities, but his focus, like that of Chinese leader Xi Jinping, has shifted toward extending human life indefinitely.

During a meeting last year, Putin and Xi discussed strategies for “living forever,” reflecting a broader global obsession with longevity—one that often overshadows efforts to improve health equity for all.